Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review

BACKGROUND: Infants < 3 months of age are at highest risk for developing severe complications after pertussis. The majority of pregnant women has low concentrations of pertussis-specific antibodies and thus newborns are insufficiently protected by maternally transferred antibodies. Acellular pert...

Descripción completa

Detalles Bibliográficos
Autores principales: Vygen-Bonnet, Sabine, Hellenbrand, Wiebke, Garbe, Edeltraut, von Kries, Rüdiger, Bogdan, Christian, Heininger, Ulrich, Röbl-Mathieu, Marianne, Harder, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020352/
https://www.ncbi.nlm.nih.gov/pubmed/32054444
http://dx.doi.org/10.1186/s12879-020-4824-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020352/
https://www.ncbi.nlm.nih.gov/pubmed/32054444
http://dx.doi.org/10.1186/s12879-020-4824-3

Ejemplares similares